TXN and cancer: Although, several defensins (71) have been reported to be cytotoxic to cancer cells (Table in Figure 6A) they shared little sequence homology with MsDef1 and none of them were shown to bind GluCer, permeate cells, synergize with Doxorubicin, and hit the intracellular tumor specific target (Trx).